Cite
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks.
MLA
Suzuki, Fumitaka, et al. “Rapid Loss of Hepatitis C Virus Genotype 1b from Serum in Patients Receiving a Triple Treatment with Telaprevir (MP-424), Pegylated Interferon and Ribavirin for 12 Weeks.” Hepatology Research, vol. 39, no. 11, Nov. 2009, pp. 1056–63. EBSCOhost, https://doi.org/10.1111/j.1872-034X.2009.00548.x.
APA
Suzuki, F., Akuta, N., Suzuki, Y., Sezaki, H., Yatsuji, H., Kawamura, Y., Hosaka, T., Kobayashi, M., Arase, Y., Ikeda, K., Mineta, R., Iwasaki, S., Watahiki, S., Kobayashi, M., Miyakawa, Y., & Kumada, H. (2009). Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks. Hepatology Research, 39(11), 1056–1063. https://doi.org/10.1111/j.1872-034X.2009.00548.x
Chicago
Suzuki, Fumitaka, Norio Akuta, Yoshiyuki Suzuki, Hitomi Sezaki, Hiromi Yatsuji, Yusuke Kawamura, Tetsuya Hosaka, et al. 2009. “Rapid Loss of Hepatitis C Virus Genotype 1b from Serum in Patients Receiving a Triple Treatment with Telaprevir (MP-424), Pegylated Interferon and Ribavirin for 12 Weeks.” Hepatology Research 39 (11): 1056–63. doi:10.1111/j.1872-034X.2009.00548.x.